Methohexitone-induced convulsions in epileptics

Area of Science:

• Neurology
• Clinical Neurophysiology

Background:

• Methohexitone is an anesthetic agent with a known, though variable, risk of precipitating convulsions in epileptic individuals.
• Anticonvulsant medication is typically administered to mitigate seizure risk during anesthetic procedures.

Purpose of the Study:

• To investigate the incidence and types of methohexitone-induced convulsions in epileptic patients undergoing electroencephalogram (EEG) recording.
• To assess the impact of withholding anticonvulsant medication on seizure precipitation by methohexitone.

Main Methods:

• A series of 48 epileptic patients had anticonvulsant medication withheld.
• Patients underwent methohexitone-activated EEG recording.
• Seizure activity during and after methohexitone administration was monitored and documented.

Main Results:

• Two patients experienced grand mal convulsions during induction with 1.0% methohexitone.
• Two patients developed petit mal status epilepticus, and one experienced myoclonic status epilepticus after a 0.09% methohexitone infusion.
• The findings suggest a specific risk of methohexitone in precipitating seizures in epileptic or crypto-epileptic individuals.

Conclusions:

• Methohexitone administration, particularly when anticonvulsant medication is withheld, poses a significant risk of inducing various seizure types in epileptic patients.
• The study supports the specific association between methohexitone and seizure precipitation in susceptible individuals.
• Further research may be warranted to establish safer protocols for EEG recordings in epileptic patients.